Boryung Biopharma Co.
Latest round
- Series B
Last raised
- Jun 2020
Total raised
- $57M
Investors
- 3
About Boryung Biopharma Co.
, Ltd. is engaged in biopharmaceutical development, with its headquarters in Seoul, South Korea. The company recently underwent a significant shift, as Eugene Private Equity and Korea Development Bank acquired an 80% majority stake in the company for KRW 320 billion on July 27, 2024. Prior to this, Boryung Biopharma had been involved in a total of five deals.Boryung Biopharma focuses on the development and production of biopharmaceuticals, particularly in the fields of oncology and autoimmune diseases. Their core product offerings include innovative therapeutic solutions designed to address complex medical needs, enhancing the quality of life for patients facing serious health challenges. The company's flagship products are aimed at both healthcare providers and patients requiring effective treatment options, with a strong emphasis on safety and efficacy. Boryung Biopharma primarily serves hospitals and clinics, with a growing presence in the Asian markets, particularly South Korea, Japan, and China.60. The company operates on a transactional model that includes direct sales to healthcare institutions and partnerships with distributors across various regions. Revenue generation is primarily from the sale of biopharmaceutical products, typically sold through agreements with hospitals and healthcare networks.Following the recent acquisition and investment, Boryung Biopharma is poised for growth through the expansion of its product line and market presence. The company plans to launch new products focused on addressing unmet medical needs in oncology and autoimmune treatment areas, with specific release dates pending further development. Additionally, Boryung Biopharma aims to enter new markets in Southeast Asia and expand its footprint in existing markets within Japan and China by the end of 2025.
Who invested in Boryung Biopharma Co.
3 investors across 2 rounds
See all investors in Boryung Biopharma Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Boryung Biopharma Co.
Who invested in Boryung Biopharma Co.?
Boryung Biopharma Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Boryung Biopharma Co. raised?
Boryung Biopharma Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Boryung Biopharma Co. last raise money?
Boryung Biopharma Co.'s most recent round on record is a Series B, in Jun 2020.
What does Boryung Biopharma Co. do?
Boryung Biopharma Co. is a biotechnology company.
Where is Boryung Biopharma Co. headquartered?
Boryung Biopharma Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Boryung Biopharma Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Boryung Biopharma Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Boryung Biopharma Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.